IPCA LABORATORIES LTD.

NSE : IPCALABBSE : 524494ISIN CODE : INE571A01038Industry : Pharmaceuticals & DrugsHouse : Ipca Laboratories
BSE1337.3511.35 (+0.86 %)
PREV CLOSE ( ) 1326.00
OPEN PRICE ( ) 1333.75
BID PRICE (QTY) 1336.45 (6)
OFFER PRICE (QTY) 1338.05 (1)
VOLUME 3460
TODAY'S LOW / HIGH ( )1329.20 1341.30
52 WK LOW / HIGH ( )670 1373.95
NSE1335.406.95 (+0.52 %)
PREV CLOSE( ) 1328.45
OPEN PRICE ( ) 1330.00
BID PRICE (QTY) 1335.40 (3)
OFFER PRICE (QTY) 1335.65 (1)
VOLUME 127957
TODAY'S LOW / HIGH( ) 1330.00 1343.95
52 WK LOW / HIGH ( )669.8 1374.6
Peer Companies Price () Chg () Chg (%) EPS () TTM P/E Volume (000's) 1 Year Return (%)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.